P090015/S014: BOND Oracle HER2 IHC System
FDA’s recorded scope: a manufacturing QC change
Explore this company’s associated devices, FDA decisions and regulatory history.

MedtechLedger currently links 1 FDA record to the applicant name Leica Biosystems. 1 entry is a 30-day notice. These are records held by this publication, rather than a count of the company’s entire portfolio.
The dated entries run from Jun 4, 2026 to Jun 4, 2026. Individual filings may concern different products or changes to an existing application; review the identifier and decision scope on each record.
Product code MVC appears in 1 of the 1 linked filings. The collection spans 1 FDA product code and 1 original PMA application family. These figures describe the filings available here; they do not establish the company’s total device sales or market share.
The largest PMA family in this collection is P090015, with 1 linked entry. Follow the parent application and its dated supplements to distinguish the original device scope from later changes.
Applicant mailing address recorded by FDA: 36 Cherry Hill Dr., Danvers, MA, 01923. Recorded on P090015/S014, decision dated Jun 4, 2026.
FDA’s recorded scope: a manufacturing QC change
Subsidiaries and similarly named applicants can have separate records. The links below preserve the applicant and submission identifiers. Source records are linked on each filing.
| Product / regulatory record | Company | Pathway | Decision date | Source |
|---|---|---|---|---|
BOND Oracle HER2 IHC SystemP090015/S014 | Leica Biosystems | PMA supplement | Jun 4, 2026 | FDA |
Source updated Nov 9, 2026. Retrieved Nov 20, 2026.